Separation and Quantification of Key Starting Materials of Irbesartan Using Liquid Chromatography–Mass Spectrometry as a Separation and Identification Tool

REFERENCES

• Cazaubon , C. , J. Gougat , F. Bousquet , P. Guiraudou , R. Gayraud , C. Lacour , et al. . 1993 . Pharmacological characterization of SR 47436, a new nonpeptide AT1 angiotensin II receptor antagonist . J. Pharmacol. Exp. Ther. 265 : 826 – 834 .
   PubMed Web of Science ®Google Scholar
• Chang , S. Y. , D. B. Whigan , N. N. Vachharanjani , and R. Patel . 1997 . High-performance liquid chromatographic assay for the quantification of irbesartan (SR 47436/BMS-186295) in human plasma and urine . J. Chromatogr. B 702 : 149 – 155 .
   PubMedGoogle Scholar
• Erk , N. 2003a . Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography . J. Chromatogr. B 784 : 195 – 201 .
   PubMed Web of Science ®Google Scholar
• Erk , N. 2003b . Three new spectrophotometric methods applied to the simultaneous determination of hydrochlorothiazide and irbesartan . Pharmazie 58 : 543 – 548 .
   PubMedGoogle Scholar
• Hillaert , S. , and W. Vanden-Bossche . 2003 . Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis . J. Pharm. Biomed. Anal. 31 : 329 – 339 .
   PubMed Web of Science ®Google Scholar
• Hillaert , S. , and W. Vanden-Bossche . 2002 . Optimization and validation of a capillary zone electrophoretic method for the analysis of several angiotensin-II-receptor antagonists . Chromatrogr. A 979 : 323 – 333 .
   PubMed Web of Science ®Google Scholar
• Isabel , I. , V. Rodenas , S. Garcia , and C. Sanchez-Pedreno . 2002 . Determination of irbesartan in the presence of hydrochlorothiazide by derivative spectrophotometry . J. Pharm. Biomed. Anal. 29 : 299 – 305 .
   PubMedGoogle Scholar
• Li , J. , Q. Wu , and L. Wang . 2001 . Assay of irbesartan tablets by HPLC . Yaowu Fenxi Zazhi 21 : 249 – 250 .
   Google Scholar
• Markham , A. , C. M. Spencer , and B. Jarvis . 2000 . Irbesartan: An updated review of its use in cardiovascular disorders . Drugs 59 : 1187 – 1206 .
   PubMed Web of Science ®Google Scholar
• Martindale the Extra Pharmacopoeia, 33rd ed. 2002 . London : Royal Pharmaceutical Society .
   Google Scholar
• Rahman , N. , M. R. Siddiqui , and S. N. Hejaz Azmi . 2006 . Quantitative analysis of irbesartan in commercial dosage forms by kinetic spectrophotometry . Chem. Pharm. Bull. 54 : 626 – 631 .
   PubMed Web of Science ®Google Scholar
• Sane , R. T. , M. Francis , and S. Pawar . 2002 . Determination of irbesartan in pharmaceutical dosage forms by HPTLC . Indian Drugs 39 : 32 – 35 .
   Google Scholar
• United States Pharmacopoeia-30 , 2007 . NF-25, Asian Edition , Vol. 2 .
   Google Scholar
• Voyksner , R. D. 2004 . Advanced LC/MSD Trap Applications . LC-MS Limited, Durham, N, Co , USA .
   Google Scholar